Literature DB >> 21484243

Reduced plasma levels of P-selectin and L-selectin in a pilot study from Alzheimer disease: relationship with neuro-degeneration.

Massimiliano M Corsi1, Federico Licastro, Elisa Porcellini, Giada Dogliotti, Emanuela Galliera, John L Lamont, Paul J Innocenzi, Stephen P Fitzgerald.   

Abstract

Neurodegenerative processes associated with Alzheimer's disease (AD) are accompanied by reactive astrogliosis and microglia activation and a role for chronic inflammation in the brain degeneration of these patients has been suggested. Moreover impaired immune functions in AD brains might also influence the disease's progression. Therefore, it is of interest to further characterized inflammatory molecules in the peripheral blood of patients with AD and its relationship with cognitive decline. A complex picture emerged in this pilot study and IL-8, IFN-gamma, MCP-1 and VEGF levels were increased in AD. Levels of P-selectin and L-selectin were decreased in AD and lowest in AD patients with highest cognitive decline. Our findings suggest that these molecules may induce alterations of endothelial regulation and influence neurodegenerative processes of AD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21484243     DOI: 10.1007/s10522-011-9335-6

Source DB:  PubMed          Journal:  Biogerontology        ISSN: 1389-5729            Impact factor:   4.277


  15 in total

Review 1.  Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Current Evidence and Future Perspectives.

Authors:  Donovan A McGrowder; Fabian Miller; Kurt Vaz; Chukwuemeka Nwokocha; Cameil Wilson-Clarke; Melisa Anderson-Cross; Jabari Brown; Lennox Anderson-Jackson; Lowen Williams; Lyndon Latore; Rory Thompson; Ruby Alexander-Lindo
Journal:  Brain Sci       Date:  2021-02-10

2.  Multiple loci influencing hippocampal degeneration identified by genome scan.

Authors:  Scott A Melville; Jacqueline Buros; Antonio R Parrado; Badri Vardarajan; Mark W Logue; Li Shen; Shannon L Risacher; Sungeun Kim; Gyungah Jun; Charles DeCarli; Kathryn L Lunetta; Clinton T Baldwin; Andrew J Saykin; Lindsay A Farrer
Journal:  Ann Neurol       Date:  2012-06-28       Impact factor: 10.422

3.  Expression level of vascular endothelial growth factor in hippocampus is associated with cognitive impairment in patients with Alzheimer's disease.

Authors:  Huidong Tang; XiaoOu Mao; Lin Xie; David A Greenberg; Kunlin Jin
Journal:  Neurobiol Aging       Date:  2012-11-24       Impact factor: 4.673

4.  Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer's disease.

Authors:  Elisa Porcellini; Manuela Ianni; Ilaria Carbone; Massimo Franceschi; Federico Licastro
Journal:  Immun Ageing       Date:  2013-02-21       Impact factor: 6.400

5.  The clinical correlation of proinflammatory and anti-inflammatory biomarkers with Alzheimer disease: a meta-analysis.

Authors:  Urati Anuradha; Anoop Kumar; Rakesh Kumar Singh
Journal:  Neurol Sci       Date:  2021-05-25       Impact factor: 3.830

6.  Alzheimer's disease and HLA-A2: linking neurodegenerative to immune processes through an in silico approach.

Authors:  Ricardo A Cifuentes; Juan Murillo-Rojas
Journal:  Biomed Res Int       Date:  2014-08-17       Impact factor: 3.411

Review 7.  Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.

Authors:  Frederic Brosseron; Marius Krauthausen; Markus Kummer; Michael T Heneka
Journal:  Mol Neurobiol       Date:  2014-02-25       Impact factor: 5.590

8.  The Cognition and Affect after Stroke - a Prospective Evaluation of Risks (CASPER) study: rationale and design.

Authors:  Elles Douven; Syenna H J Schievink; Frans R J Verhey; Robert J van Oostenbrugge; Pauline Aalten; Julie Staals; Sebastian Köhler
Journal:  BMC Neurol       Date:  2016-05-12       Impact factor: 2.474

9.  Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline.

Authors:  Matthew McMillin; Gabriel Frampton; Michelle Thompson; Cheryl Galindo; Holly Standeford; Eric Whittington; Gianfranco Alpini; Sharon DeMorrow
Journal:  J Neuroinflammation       Date:  2014-07-10       Impact factor: 8.322

Review 10.  Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases.

Authors:  Anna A Boyko; Natalya I Troyanova; Elena I Kovalenko; Alexander M Sapozhnikov
Journal:  Int J Mol Sci       Date:  2017-12-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.